Nevro Corp. – NYSE:NVRO
Nevro Corp. stock price today
$5.84
+2.11
+56.99%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 4 hours
Nevro Corp. stock price monthly change
-59.43%
month
Nevro Corp. stock price quarterly change
-59.43%
quarter
Nevro Corp. stock price yearly change
-83.33%
year
Nevro Corp. key metrics
Market Cap | 136.02M |
Enterprise value | 1.34B |
P/E | 445.75 |
EV/Sales | 3.30 |
EV/EBITDA | 63.82 |
Price/Sales | 3.11 |
Price/Book | 3.90 |
PEG ratio | 4.36 |
EPS | -2.29 |
Revenue | 430.74M |
EBITDA | -75.88M |
Income | -82.59M |
Revenue Q/Q | 5.78% |
Revenue Y/Y | 3.83% |
Profit margin | 0.74% |
Oper. margin | -24.32% |
Gross margin | 68.01% |
EBIT margin | -24.32% |
EBITDA margin | -17.62% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNevro Corp. stock price history
Nevro Corp. stock forecast
Nevro Corp. financial statements
Average Price Target
$6.11
Potential upside: 4.64%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 108.80M | -24.72M | -22.72% |
|---|---|---|---|
| Sep 2023 | 103.86M | -23.47M | -22.61% |
| Dec 2023 | 116.17M | -8.98M | -7.73% |
| Mar 2024 | 101.89M | -25.40M | -24.94% |
| 2023-04-26 | -1.04 | -0.98 |
|---|
| Jun 2023 | 569518000 | 274.76M | 48.25% |
|---|---|---|---|
| Sep 2023 | 561582000 | 275.91M | 49.13% |
| Dec 2023 | 635713000 | 330.31M | 51.96% |
| Mar 2024 | 596050000 | 317.50M | 53.27% |
| Jun 2023 | -14.50M | 11.27M | 4.12M |
|---|---|---|---|
| Sep 2023 | -6.09M | 7.28M | -1.01M |
| Dec 2023 | -14.75M | -1.11M | 54.52M |
| Mar 2024 | -32.92M | 25.32M | -6.21M |
Nevro Corp. alternative data
| Aug 2023 | 1,087 |
|---|---|
| Sep 2023 | 1,087 |
| Oct 2023 | 1,087 |
| Nov 2023 | 1,087 |
| Dec 2023 | 1,087 |
| Jan 2024 | 1,087 |
| Feb 2024 | 1,087 |
| Mar 2024 | 1,215 |
| Apr 2024 | 1,215 |
| May 2024 | 1,215 |
| Jun 2024 | 1,215 |
| Jul 2024 | 1,215 |
Nevro Corp. other data
88.55%
-7.79%
of NVRO is owned by hedge funds
160
-13
31.27M
-2.51M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2023 | 7500 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | MCCORMICK SHAWN director | Common Stock | 7,500 | $22.88 | $171,630 | ||
Option | DEMANE MICHAEL F director | Common Stock | 80,291 | $18 | $1,445,238 | ||
Option | DEMANE MICHAEL F director | Stock Option (Right to Buy) | 80,291 | $18 | $1,445,238 | ||
Purchase | RASHID KASHIF officer: General .. | Common Stock | 2,250 | $44.5 | $100,127 | ||
Purchase | RASHID KASHIF officer: General .. | Common Stock | 1,500 | $64.05 | $96,068 | ||
Purchase | GROSSMAN D KEITH director, officer.. | Common Stock | 3,200 | $63.59 | $203,488 | ||
Purchase | OBOYLE KEVIN C director | Common Stock | 1,400 | $83.8 | $117,320 | ||
Purchase | OBOYLE KEVIN C director | Common Stock | 1,000 | $83.75 | $83,750 | ||
Purchase | WEATHERMAN ELIZABETH H director | Common Stock | 9,297 | $84.86 | $788,897 | ||
Purchase | WEATHERMAN ELIZABETH H director | Common Stock | 10,703 | $85.74 | $917,654 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 21 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 1 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
Nevro: Potentially Better Than Traditional SCS Treatment For Pain And Undervalued
Nevro: Treating Patient Back Pains, Causing Shareholder Back Pains
Nevro: Recent Developments Corroborate Breakout, Revise To Buy
Nevro: FDA Approved Lower Back Pain Relief Without Opiates Or Surgery
Nevro: A Top Recovery Play As Covid Abates
Nevro: Harvesting An Epic Growth Opportunity
-
What's the price of Nevro Corp. stock today?
One share of Nevro Corp. stock can currently be purchased for approximately $5.84.
-
When is Nevro Corp.'s next earnings date?
Unfortunately, Nevro Corp.'s (NVRO) next earnings date is currently unknown.
-
Does Nevro Corp. pay dividends?
No, Nevro Corp. does not pay dividends.
-
How much money does Nevro Corp. make?
Nevro Corp. has a market capitalization of 136.02M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.63% to 425.17M US dollars. Nevro Corp. made a loss 92.21M US dollars in net income (profit) last year or -$0.98 on an earnings per share basis.
-
What is Nevro Corp.'s stock symbol?
Nevro Corp. is traded on the NYSE under the ticker symbol "NVRO".
-
What is Nevro Corp.'s primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Nevro Corp.?
Shares of Nevro Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Nevro Corp.'s key executives?
Nevro Corp.'s management team includes the following people:
- Mr. D. Keith Grossman Chairman, Chief Executive Officer & Pres(age: 65, pay: $1,400,000)
- Mr. Andrew H. Galligan Executive Officer(age: 69, pay: $776,950)
- Mr. Kashif Rashid Gen. Counsel, Corporation Sec. & Chief Compliance Officer(age: 51, pay: $605,570)
- Mr. Roderick H. MacLeod Chief Financial Officer(age: 58, pay: $546,900)
-
How many employees does Nevro Corp. have?
As Jul 2024, Nevro Corp. employs 1,215 workers.
-
When Nevro Corp. went public?
Nevro Corp. is publicly traded company for more then 10 years since IPO on 6 Nov 2014.
-
What is Nevro Corp.'s official website?
The official website for Nevro Corp. is nevro.com.
-
Where are Nevro Corp.'s headquarters?
Nevro Corp. is headquartered at 1800 Bridge Parkway, Redwood City, CA.
-
How can i contact Nevro Corp.?
Nevro Corp.'s mailing address is 1800 Bridge Parkway, Redwood City, CA and company can be reached via phone at +65 02510005.
-
What is Nevro Corp. stock forecast & price target?
Based on 7 Wall Street analysts` predicted price targets for Nevro Corp. in the last 12 months, the avarage price target is $6.11. The average price target represents a 4.64% change from the last price of $5.84.
Nevro Corp. company profile:
Nevro Corp.
nevro.comExchange:
NYSE
Full time employees:
1,215
Industry:
Medical - Devices
Sector:
Healthcare
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
1800 Bridge Parkway
Redwood City, CA 94065
Redwood City, CA 94065
CIK: 0001444380
ISIN: US64157F1030
CUSIP: 64157F103
